Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Establishment inspection reports

This article was originally published in The Tan Sheet

Executive Summary

Establishment inspection reports: FDA automatically will provide inspected companies with a copy of the agency's final EIR, beginning in April. The EIR will be provided as soon as FDA has determined that the inspected facility is in compliance with agency guidelines. Previously, inspected firms had to file for the EIR through FDA's Freedom of Information Act office. The change comes in response to industry complaints that third parties could receive copies of the EIR before the inspected company through FoI...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel